Log in to save to my catalogue

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein funct...

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein funct...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1de9aa4def1445c6b15847a2a21ee1b1

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk

About this item

Full title

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-02, Vol.13 (1), p.1899-1899, Article 1899

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

High-density lipoprotein (HDL) cholesterol efflux capacity (CEC), which is a conventional metric of HDL function, has been associated with coronary heart disease risk. However, the CEC assay requires cultured cells and takes several days to perform. We previously established a cell-free assay to evaluate cholesterol uptake capacity (CUC) as a novel...

Alternative Titles

Full title

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1de9aa4def1445c6b15847a2a21ee1b1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1de9aa4def1445c6b15847a2a21ee1b1

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-28953-x

How to access this item